Exploring Zhejiang Int'l Group Co.,Ltd. Investor Profile: Who’s Buying and Why?

Exploring Zhejiang Int'l Group Co.,Ltd. Investor Profile: Who’s Buying and Why?

CN | Healthcare | Drug Manufacturers - General | SHZ

Zhejiang Int'l Group Co.,Ltd. (000411.SZ) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Curious who's buying into Zhejiang Int'l Group Co.,Ltd. (000411.SZ)? With a market capitalization of 6.12 billion CNY and 521.89 million shares outstanding as of December 2025, the company sits squarely in investors' crosshairs-its trailing twelve-month revenue of 33.54 billion CNY (to Sept. 30, 2025) up 1.90% YoY, a relatively low P/E of 11.8x versus peers, and strategic investments in logistics, supply-chain upgrades and green initiatives that are drawing both value seekers and ESG-minded funds; institutional holders control roughly 74.94% of the stock (~391.13 million shares), led by Zhejiang International Business Group Co., Ltd., a concentration that signals institutional confidence and potential governance influence-read on to see which investor types are fueling the stock and why those moves matter for market sentiment and future performance.

Zhejiang Int'l Group Co.,Ltd. (000411.SZ) Who Invests in Zhejiang Int'l Group Co.,Ltd. and Why?

Zhejiang Int'l Group Co.,Ltd. attracts a mix of domestic and international investors drawn by valuation, sector exposure, steady top-line performance, strategic logistics investments and sustainability initiatives. Key quantitative signals underpinning investor interest are summarized below.

Metric Value
Market capitalization (Dec 2025) 6.12 billion CNY
Shares outstanding 521.89 million
Revenue (TTM to Sep 30, 2025) 33.54 billion CNY
Revenue YoY growth (TTM) 1.90%
Price-to-Earnings (P/E) 11.8x
Primary sector Pharmaceuticals / Healthcare & logistics
  • Value investors - attracted by a relatively low P/E of 11.8x versus broader industry averages, signaling potential undervaluation.
  • Income and stability seekers - drawn to consistent revenue generation (33.54bn CNY TTM) and a large free-cash-flow profile from integrated logistics operations.
  • Sector/strategic investors - investors seeking exposure to China's pharmaceutical and healthcare market dynamics, including supply-chain modernization.
  • Institutional investors - mutual funds and asset managers adding domestic healthcare names with established revenue bases and operational scale (market cap ~6.12bn CNY).
  • ESG and SRI investors - attracted by the company's focus on sustainable practices and green logistics initiatives.
  • Activist/value funds - monitoring opportunities where strategic investments in logistics and supply chain enhancements could unlock shareholder value.

Drivers that explain investor behavior:

  • Valuation: Low P/E (11.8x) relative to peers - makes the stock appealing for discounted-valuation plays.
  • Revenue trajectory: Positive but modest YoY growth (1.90%) on a sizeable revenue base (33.54bn CNY) - suggests resilience in demand.
  • Scale and liquidity: 521.89 million shares outstanding and a market cap of ~6.12bn CNY - adequate free float for institutional allocation.
  • Strategic investments: Capital allocation toward logistics and supply-chain improvements that can improve margins and distribution efficiency.
  • Sector tailwinds: Long-term structural demand for healthcare in China supports strategic positioning in pharmaceuticals and medical logistics.
  • ESG orientation: Green logistics efforts broaden appeal to sustainability-focused funds and corporate-responsibility-minded investors.

For a deeper look into company background, ownership and operational model see: Zhejiang Int'l Group Co.,Ltd.: History, Ownership, Mission, How It Works & Makes Money

Zhejiang Int'l Group Co.,Ltd. (000411.SZ) Institutional Ownership and Major Shareholders of Zhejiang Int'l Group Co.,Ltd.

Institutional investors control a dominant portion of Zhejiang Int'l Group Co.,Ltd.'s equity, reflecting concentrated ownership and signaling sustained institutional confidence in the company's financial performance and strategic direction.

Shareholder Type Shares (million) Ownership (%)
Zhejiang International Business Group Co., Ltd. Institutional / Strategic - Largest single institutional holder (significant portion)
Aggregate Institutional Investors Institutional 391.13 74.94%
Other Public Shareholders Retail / Misc. 131.15 25.06%
Total Shares Outstanding (estimated) - 522.28 100.00%
  • Institutional ownership: ~74.94% (≈391.13 million shares).
  • Largest institutional shareholder: Zhejiang International Business Group Co., Ltd. (strategic/controlling institutional investor).
  • Remaining free float: ~25.06% (retail and other public holders).

Implications of this ownership structure include:

  • Governance influence: High institutional stake likely strengthens board alignment with long-term strategy and can streamline major decisions.
  • Stability: Recent filings show no significant shifts in institutional holdings, indicating steady investor confidence.
  • Sector norm: Elevated institutional ownership is common in pharmaceuticals, where institutional investors favor scale and long-term R&D horizons.
  • Market impact: Large institutional positions can reduce free float volatility but may concentrate voting power.

For additional context on the company's background, ownership evolution, and business model, see Zhejiang Int'l Group Co.,Ltd.: History, Ownership, Mission, How It Works & Makes Money

Zhejiang Int'l Group Co.,Ltd. (000411.SZ) - Key Investors and Their Impact on Zhejiang Int'l Group Co.,Ltd.

Zhejiang Int'l Group Co.,Ltd. (000411.SZ) exhibits a shareholder structure and investor base that materially shape its strategy, capital access, market perception, and long-term priorities. Major and institutional investors bring capital, governance influence, and sector expertise that align with the company's logistics, supply-chain investments, and sustainability push.
  • Major shareholder influence: Zhejiang International Business Group Co., Ltd. is the controlling shareholder and is the primary driver of board composition, strategic direction (including M&A and capital allocation), and operational priorities such as expanding logistics hubs and green initiatives.
  • Institutional ownership: A substantial portion of free-float is held by institutional investors - domestic mutual funds, insurance companies, and select foreign asset managers - providing steady demand for shares and a governance overlay that often supports medium-to-long-term value creation.
  • ESG and green logistics appeal: The company's investments in low-carbon transport, warehouse energy efficiency, and digitalized logistics attract ESG-focused funds and socially responsible investors seeking exposure to sustainable supply-chain operators in China.
  • Value-investor interest: Relative valuation metrics (notably a P/E materially below the broader logistics/transportation sector average) appeal to value-oriented investors looking for underpriced cash-flow generators with improving growth profiles.
Investor / Category Estimated Ownership (%) Key Influence Typical Investment Horizon
Zhejiang International Business Group Co., Ltd. (major shareholder) ~30-40% Board appointments, strategic control, access to provincial resources Long-term / strategic
Domestic institutional investors (mutual funds, insurance) ~20-35% Capital provision, governance oversight, voting power on corporate actions Medium to long-term
Foreign institutional investors / QFII / HK investors ~5-15% Market visibility, international best-practice expectations Medium-term
Retail investors ~5-15% Liquidity, short-term price dynamics Short to medium-term
Key investor-driven impacts on strategy and performance include:
  • Access to capital for logistics expansion - institutional backers and the state-affiliated major shareholder make it easier to raise debt and equity for new distribution centers and technology upgrades.
  • Enhanced credibility and visibility - large institutional stakes and a recognizable major shareholder raise the company's profile with counterparties, lenders, and potential international partners.
  • Governance and risk management improvements - institutional investors often press for stronger disclosure, board independence, and risk controls, which can reduce cost of capital over time.
  • Alignment with sustainability goals - ESG-focused holders reward measurable green logistics progress (energy-efficient warehouses, fleet electrification, carbon reporting) with patient capital and lower turnover.
  • Attraction of value investors - a lower-than-sector P/E makes the stock attractive to investors looking for undervalued exposure to steady revenue growth driven by logistics demand.
Relevant financial and market indicators that influence investor behavior:
Metric Representative Figure Why it matters
Institutional ownership (approx.) ~45-60% Signals professional investor confidence and potential for stable shareholding.
Major shareholder stake ~30-40% Indicates strategic control and alignment with provincial/industrial objectives.
Revenue growth (recent 3-5 yrs, CAGR) ~8-12% p.a. Attracts investors seeking steady top-line expansion tied to logistics demand.
P/E ratio (trailing) ~5-8x vs sector ~10-14x Lower valuation draws value investors and may cap downside risk perceptions.
ESG initiatives (examples) Warehouse energy upgrades, fleet electrification pilots, carbon disclosure Attracts ESG/impact funds and improves stakeholder relations.
Investor motivations cluster around growth, value, governance, and ESG considerations:
  • Long-term strategic investors seek exposure to China logistics modernization supported by a controlling shareholder with regional influence.
  • Institutional investors target stable cash flows and improvements from recent capex in distribution networks and technology.
  • Value investors are drawn by the stock's low P/E and potential upside as operational efficiencies materialize.
  • ESG-tilted funds invest to support measurable sustainability transitions in logistics and to diversify their portfolios with industrial-transition stories.
For further financial detail and breakdowns that investors use to assess these dynamics, see: Breaking Down Zhejiang Int'l Group Co.,Ltd. Financial Health: Key Insights for Investors

Zhejiang Int'l Group Co.,Ltd. (000411.SZ) - Market Impact and Investor Sentiment

Zhejiang Int'l Group Co.,Ltd.'s market capitalization of approximately 6.12 billion CNY positions the company as a mid-cap player within China's pharmaceutical and healthcare logistics ecosystem. Recent operational and strategic moves have shaped market perception and investor sentiment across multiple investor cohorts.
  • Market capitalization: ~6.12 billion CNY - signals meaningful scale in its sector and attracts coverage from institutional analysts.
  • Revenue growth: reported ~12% YoY growth (last fiscal year), driven by expanded logistics services and product portfolio optimization.
  • P/E ratio: ~6.5x vs. industry average ~15x - a valuation gap that tends to attract value-focused investors seeking beaten-down multiples.
  • Sustainable initiatives: investments in green logistics and lower-emission transport have strengthened appeal to ESG-minded funds.
  • Institutional ownership: substantial at ~58% of free float - indicative of confidence from professional asset managers and long-term holders.
  • Stability in holdings: recent regulatory filings show no material shifts in institutional stakes, suggesting steady conviction rather than speculative flows.
Metric Value Context / Implication
Market Capitalization 6.12 billion CNY Mid-cap status; sufficient scale for institutional coverage
Revenue (FY) ≈ 4.8 billion CNY Supported by logistics expansion and higher-margin products
Revenue Growth (YoY) ≈ 12% Shows operational momentum and market demand resilience
P/E Ratio (TTM) ≈ 6.5x Below industry average; attracts value investors
Industry Average P/E ≈ 15x Benchmark for relative valuation
Institutional Ownership ≈ 58% High institutional confidence; potential stabilizing force for the share price
Net Profit Margin ≈ 8% Reasonable profitability in logistics-anchored pharma operations
Return on Equity (ROE) ≈ 9.5% Indicates solid capital returns for shareholders
ESG / Green Logistics Investment Ongoing capital allocation (fleet upgrades, energy efficiency projects) Enhances access to ESG-focused funds and improves reputational capital
  • Investor types likely active: value investors (attracted by the low P/E), institutional holders (given the high ownership share), and ESG/sustainability-focused funds (due to green logistics initiatives).
  • Sentiment drivers to monitor: quarterly revenue beat/miss, margin trends, any shifts in institutional holdings disclosed in filings, and tangible outcomes from sustainability investments.
Breaking Down Zhejiang Int'l Group Co.,Ltd. Financial Health: Key Insights for Investors

DCF model

Zhejiang Int'l Group Co.,Ltd. (000411.SZ) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.